Profile

Anthony J. Bleyer, M.D.Wake Forest Baptist Health

Doctor Rating

4.8 out of 5

91 Ratings
16 Comments

Anthony J. Bleyer, M.D.

Professor,

Clinical Interests

Nephrology, Genetic Renal Disease, Diabetic Kidney Disease, Genetics, Kidney Disease, Clinical Nephrology, Dialysis

Contact Information

New Patient Appointments: 336-716-WAKE
Returning Patient Appointments: 336-716-4513
Department: 336-716-4650

Insurance Accepted »

Education & Training

  • B.S., Rensselaer PolyTechnical Institute, 1982
  • M.D., Baylor College of Medicine, 1987
  • Internship, Internal Medicine, Johns Hopkins Affil Hosps, 1988
  • Residency, Internal Medicine, Johns Hopkins Affil Hosps, 1990
  • Fellowship, University of Pennsylvania Sch, 1992

Board Certifications

  • American Board of Internal Medicine, Internal Medicine
  • American Board of Internal Medicine, Internal Medicine, Nephrology

Memberships

  • Int'L Society Of Nephrology
  • Int'L Society Peritoneal Dialy
  • Nat'L Kidney Foundation
  • Am Soc Of Nephrology

NPI Number

  • 1346225778
Anthony J. Bleyer, M.D.

Doctor Rating

4.8 out of 5

91 Ratings
16 Comments

Anthony J. Bleyer, M.D.

Professor, Nephrology

Research Interests

drugs/therapeutic agents pharm, genetics/genome, genomics and proteomics, surgery/trauma/burns/trauma

Contact Information

Academic: 336-716-4513 | Department: 336-716-4650

Recent Publications

Eckardt KU, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O. Autosomal dominant tubulointerstitial kidney disease: diagnosis, classification, and management-A KDIGO consensus report. Kidney Int. 2015;():.

Bleyer AJ, Wright D, Alcorn H. Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis. Clin Nephrol. 2015;83(5):286-292.

Bleyer AJ, Kmoch S, Antignac C, Robins V, Kidd K, Kelsoe JR, Hladik G, Klemmer P, Knohl SJ, Scheinman SJ, Vo N, Santi A, Harris A, Canaday O, Weller N, Hulick PJ, Vogel K, Rahbari-Oskoui FF, Tuazon J, Deltas C, Somers D, Megarbane A,. Variable clinical presentation of an MUC1 mutation causing medullary cystic kidney disease type 1. Clin J Am Soc Nephrol. 2014;9(3):527-535.

Murea M, James KM, Russell GB, Byrum GV III, Yates JE, Tuttle NS, Bleyer AJ, Burkart JM, Freedman BI. Risk of catheter-related bloodstream infection in elderly patients on hemodialysis. Clin J Am Soc Nephrol. 2014;9(4):764-770.

Kovesdy CP, Lu JL, Molnar MZ, Ma JZ, Canada RB, Streja E, Kalantar-Zadeh K, Bleyer AJ. Observational modeling of strict vs conventional blood pressure control in patients with chronic kidney disease. JAMA Intern Med. 2014;174(9):1442-1449.

Bleyer AJ, Kmoch S. Autosomal dominant tubulointerstitial kidney disease: of names and genes [editorial commentary]. Kidney Int. 2014;86(3):459-461.

Bleyer AJ, Reeves-Daniel AM. A population-based study of the U.S. population shows the majority of persons cannot donate due to preventable diseases and socio-economic conditions [abstract]. J Am Soc Nephrol. 2014;25(Abstract Suppl):67A.

Abbas MM, Kidd KO, Kmoch S, Bleyer AJ. Comparison of age of onset of end-stage kidney disease in medullary cystic kidney disease types 1 and 2 [abstract]. J Am Soc Nephrol. 2014;25(Abstract Suppl):771A.

Corapi KM, McGrath MM, Bleyer AJ, Greka A. Broadening the differential of cystic kidney disease: disease [abstract]. J Am Soc Nephrol. 2014;25(Abstract Suppl):423A.

Bleyer AJ, Kmoch S, Langefeld CD, Raffield LM, Lu L, Bowden DW, Freedman BI. Uromodulin (UMOD) gene polymorphism shows different associations with chronic kidney disease in Euro-American versus African-American individuals with diabetes mellitus [abstract]. J Am Soc Nephrol. 2014;25(Abstract Suppl):418A.

Kirby A, Gnirke A, Jaffe DB, Baresova V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, Hulkova H, Sovova J, Vylet'al P, Antignac C, Guttman M, Handsaker RE,. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. Nat Genet. 2013;45(3):299-303.

Gunzler D, Bleyer AJ, Thomas RL, O Brien A, Russell GB, Sattar A, Iyengar SK, Thomas C, Sedor JR, Schelling JR. Diabetic nephropathy in a sibling and albuminuria predict early GFR decline: a prospective cohort study. BMC Nephrol. 2013;14():124.

Bleyer AJ. Clinical implications of the relationship between low calcium concentration dialysate and sudden death [editorial]. Clin J Am Soc Nephrol. 2013;8(5):706-707.

Palmer BF, Glassock RJ, Bleyer AJ. American Society of Nephrology quiz and questionnaire 2012: electrolytes. Clin J Am Soc Nephrol. 2013;8(6):1048-1053.

Brennan DC, Glassock RJ, Bleyer AJ. American Society of Nephrology quiz and questionnaire 2012: transplantation. Clin J Am Soc Nephrol. 2013;8(7):1267-1272.

Fervenza FC, Glassock RJ, Bleyer AJ. American society of nephrology quiz and questionnaire 2012: glomerulonephritis. Clin J Am Soc Nephrol. 2013;8(8):1460-1465.

Mehrotra R, Glassock RJ, Bleyer AJ. American society of nephrology quiz and questionnaire 2012: renal replacement therapy. Clin J Am Soc Nephrol. 2013;8(9):1632-1636.

Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K. Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study. Ann Intern Med. 2013;159(4):233-242.

Robinson TW, Bleyer AJ. Kidney transplant exposing central diabetes insipidus [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):288A.

Bleyer AJ, Kmoch S, Kidd KO, Robins VC, Hodanova K. Variable clinical presentation in individuals with a MUC1 mutation causing medullary cystic kidney disease type 1 [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):304A.

Murea M, James KM, Russell GB, Bleyer AJ, Burkart JM, Freedman BI. Risk of catheter-related bloodstream infections in elderly patients on hemodialysis [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):396A.

Bleyer AJ, Wright DE, Glicklich A. Pegloticase, a recombinant uricase for the treatment of advanced gout, maintains therapeutic concentrations during dialysis [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):461A.

Hashim FQ, Bleyer AJ, Kmoch S, Neiberger RE. Renin gene mutation causing anemia and kidney injury in childhood [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):608A.

Bolanos JA, Bleyer AJ, Yuan CM, Thurlow JS. Implications of an unusual diagnosis: uromodulin-associated kidney disease [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):608A.

Bleyer AJ, Lu JL, Molnar MZ, Ma JZ, Canada RB, Kalantar-Zadeh K, Kovesdy CP. The use of a U.S. veterans' chronic kidney disease database to model the SPRINT (Systolic Blood Pressure Intervention) Trial [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):680A-681A.

Moriniere V, Hollebecque S, Lebbah S, Megarbane A, Gnirke A, Blumenstiel B, Bleyer AJ, Kirby A, Knebelmann B, Antignac C. Mutations in a large VNTR of MUC1 are frequent in autosomal dominant medullary cystic kidney disease (MCKD) [abstract]. J Am Soc Nephrol. 2013;24(Abstract Suppl):68A.

Bleyer AJ, Wright DE, Glicklich A. Pharmacokinetics and pharmacodynamics of pegloticase in patients with end-stage renal failure receiving hemodialysis [abstract]. Arthritis Rheum. 2013;65(Suppl 10):S497-S498.

Bleyer AJ, Kmoch S. Medullary cystic kidney disease type 1 In: Pagon RA, Adam MP Ardinger HH, et al, eds. GeneReviews [internet]. Seattle (WA);2013: .

Palmer BF, Glassock RJ, Bleyer AJ. Nephrology quiz and questionnaire: electrolytes. Clin J Am Soc Nephrol. 2012;7(6):1047-1052.

Bleyer AJ, Hawfield A. Cardiovascular disease: modifiable risk factors for sudden death in dialysis patients. Nat Rev Nephrol. 2012;8(6):323-324.

Hricik DE, Glassock RJ, Bleyer AJ. Nephrology quiz and questionnaire: transplantation. Clin J Am Soc Nephrol. 2012;7(7):1190-1194.

Golper TA, Glassock RJ, Bleyer AJ. Nephrology quiz and questionnaire: renal replacement therapy. Clin J Am Soc Nephrol. 2012;7(8):1347-1352.

Murea M, Moran T, Russell GB, Shihabi ZK, Byers JR, Andries L, Bleyer AJ, Freedman BI. Glycated albumin, not hemoglobin A1c, predicts cardiovascular hospitalization and length of stay in diabetic patients on dialysis. Am J Nephrol. 2012;36(5):488-496.

Bleyer AJ, Kmoch S. Gout: a step forward [editorial]. Adv Chronic Kidney Dis. 2012;19(6):356-357.

Stiburkova B, Bleyer AJ. Changes in serum urate and urate excretion with age. Adv Chronic Kidney Dis. 2012;19(6):372-376.

Murea M, Russell GB, Bleyer AJ, Freedman BI. Glycated albumin (GA), not hemoglobin A1c (HbA1c), predicts cardiovascular hospitalizations and length of stay (LOS) in dialysis patients with diabetes [abstract]. J Am Soc Nephrol. 2012;23():751A.

Bleyer AJ, Zivna M, Kmoch S. Uromodulin-associated kidney disease. Nephron Clin Pract. 2011;118(1):c31-c36.

Reeves-Daniel AM, DePalma JA, Bleyer AJ, Rocco MV, Murea M, Adams PL, Langefeld CD, Bowden DW, Hicks PJ, Stratta RJ, Lin J-J, Kiger DF, Gautreaux MD, Divers J, Freedman BI. The APOL1 gene and allograft survival after kidney transplantation. Am J Transplant. 2011;11(5):1025-1030.

Bleyer AJ, Hart PS. UMOD-associated kidney disease In: Pagon RA, Bird TD, Dolan CR, eds. GeneReviews [internet]. Seattle (WA): University of Washington;2011: NBK1356.

Kmoch S, Zivna M, Bleyer AJ. Familial juvenile hyperuricemic nephropathy type 2 In: Pagon RA, Bird TD, Dolan CR, eds. GeneReviews [internet]. Seattle (WA): University of Washington;2011: NBK53700.

Freedman BI, Andries L, Shihabi ZK, Rocco MV, Byers JR, Cardona CY, Graham AD, Mauck VL, Russell GB, Bleyer AJ, et al. Glycated albumin and risk of death and hospitalizations in diabetic dialysis patients. Clin J Am Soc Nephrol. 2011;6(7):1635-1643.

Glassock RJ, Bleyer AJ, Hricik DE, Palmer BF. The 2010 nephrology quiz and questionnaire: part 1. Clin J Am Soc Nephrol. 2011;6(9):2318-2327.

Glassock RJ, Bleyer AJ, Bargman JM, Fervenza FC. The 2010 nephrology quiz and questionnaire: part 2. Clin J Am Soc Nephrol. 2011;6(10):2534-2547.

Freedman BI, Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW. Sickle cell trait is not associated with ESRD susceptibility in African Americans [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):463A.

Bleyer AJ, Adams PL, Russell GB. Women are extremely disproportionately affected by high panel reactive antibody levels prior to kidney transplantation [abstract]. J Am Soc Nephrol. 2011;22(Abstract Suppl):956A.

Bleyer AJ, Murea M. Antimicrobial catheter locks: searching for the ideal solution [editorial]. J Am Soc Nephrol. 2011;22(10):1781-1782.

Bleyer AJ, Vidya S, Russell GB, Jones CM, Sujata L, Daeihagh P, Hire D. Longitudinal analysis of one million vital signs in patients in an academic medical center. Resuscitation. 2011;82(11):1387-1392.

Hicks PJ, Langefeld CD, Lu L, Bleyer AJ, Divers J, Nachman PH, Derebail VK, Bowden DW, Freedman BI. Sickle cell trait is not independently associated with susceptibility to end-stage renal disease in African Americans. Kidney Int. 2011;80(12):1339-1343.

Freedman BI, Shenoy RN, Planer JA, Clay KD, Shihabi ZK, Burkart JM, Sabio H, Byers JR, Russell GB, Bleyer AJ, et al. Comparison of glycated albumin and hemoglobin A1c concentrations in diabetic subjects on peritoneal and hemodialysis. Perit Dial Int. 2010;30(1):72-79.

Freedman BI, Shihabi ZK, Andries L, Cardona CY, Peacock TP, Byers JR, Russell GB, Stratta RJ, Bleyer AJ. Relationship between assays of glycemia in diabetic subjects with advanced chronic kidney disease. Am J Nephrol. 2010;31(5):375-379.

All Publications

For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.

For a list of earlier publications, visit the Carpenter Library Publication Search.

Professor, Nephrology

Clinical Interests

Nephrology, Genetic Renal Disease, Diabetic Kidney Disease, Genetics, Kidney Disease, Clinical Nephrology, Dialysis
Anthony J. Bleyer, M.D.

Anthony J. Bleyer, M.D.

Professor, Nephrology

Doctor Rating

4.8 out of 5

Anthony J. Bleyer, M.D.91 Ratings
16 Comments

Doctor Ratings

The overall Patient Rating score is the average of responses to the nine questions listed below. The questions are from the Press Ganey Patient Satisfaction Survey. Responses are measured on a 1 to 5 scale, where 1 represents "very poor" and 5 represents "very good."
Press Ganey Patient Satisfaction Survey

CP concern for questions/worries
4.8
CP efforts to include in decisions
4.8
CP explanations of prob/condition
4.8
CP spoke using clear language
4.9
Friendliness/courtesy of CP
4.8
Likelihood of recommending CP
4.9
Patients' confidence in CP
4.8
Time CP spent with patient
4.8
Wait time at clinic
4.2



Patient Comments

Comments are taken from the Care Provider section of the Press Ganey Patient Satisfaction Survey. Comments are posted exactly as they are written. Comments are added weekly. To protect patient privacy and confidentiality, patient names are not included.

6/13/2015

I fully trust Dr. Bleyer's judgement to the point that if I was unable to make a decision for myself I would certainly trust him to make the appropriate decision on my behalf as he always seems to have only my best interests in mind.

6/8/2015

Always taking time to talk with us, and explaining the things we need to know, and helping us understand it.

4/21/2015

Dr. Bleyer, has always been very honest with me and always explains what we are doing and why. I wish all doctors were as nice as he is and would explain things as easily to understand as he does.

4/7/2015

*Dr. Bleyer is an excellent doctor. I am very fortunate to have him as my doctor. He was very concerned & knowledgeable about my health issues.

3/18/2015

They are the best in the world.

3/9/2015

*Dr. Bleyer & his team continue to provide top-notch care & have my complete trust & confidence.

1/20/2015

I have been very pleased with the consistently high level of care that I have received from this provider

1/8/2015

Good.

12/17/2014

I have been seeing Dr. Bleyer between 5-7 years. I have found him to be extremely competent in the field of nephrology. He has taken untold time working with me to get my blood pressure under control to help maintain the utmost kidney function and keeping any further kidney disease at bay, thus helping the present kidney function level to remain stable. Dr. Bleyer takes time with me regarding my specific medical condition for which he treats me and also the time to see how my life is going as well. He truly cares about his patients and he remembers events/happenings in the lives of same!

10/29/2014

Dr. Bleyer is an excellent doctor. He stays on top of my kidney issues and keeps me informed. I really appreciate all he does for me.

10/15/2014

Dr. Bleyer is an excellent doctor!

10/14/2014

Good.

10/3/2014

*Dr. Anthony Bleyer, MD became my care provider in 2000 - He and his staff have always been friendly and courteous and provided me with professional care and respect over the years. He is a VERY dedicated MD and has provided me with EXCELLENT care.

10/1/2014

*Dr. Bleyer and his nursing staff are the nicest people I have met.

9/27/2014

DR BLEYER HAS BEEN TREATING ME SINCE HE HELPED DIAGONOSE MY WEGENERS IN 2000. ALSO HE TREATS MY SON WHO HAD A KIDNEY TRANSPLANT WE APPRECIATED HIM VERY MUCH AND WE ARE BOTH LUCKY TO HAVE SUCH A GREAT DR

9/8/2014

*Dr. Bleyer is always caring and concerned about my health condition. *Dr. Bleyer.

Quick Reference

Request an Appointment
New Patients

336-716-WAKE
888-716-WAKE

Existing patients may contact the clinic directly.
Find a Doctor Ways to Give
USNWR 2015-2016Magnet Hospital RecognitionConsumer Choice2014 Best DoctorsJoint Commission Report

Disclaimer: The information on this website is for general informational purposes only and SHOULD NOT be relied upon as a substitute for sound professional medical advice, evaluation or care from your physician or other qualified health care provider.